Skip to content
Menu

CERo Therapeutics Holdings, Inc. CERO

Full chart Compare
Set alert

Price alert · CERO

All alert types
0.00 USD 0.00 (+7.89%)

As ofNov 16, 2026, 3:57 PM EST

0.0041 Day range 0.0049
0.003 52-week range 0.135
YTD
-93.88%
1 year
-95.82%

Revenue & Expenses

Revenue Profit Costs
Other Income$596.00KGross Profit$20.22MNet Loss$21.65MExpenses$42.47MSelling, General & Admin$5.42MOther Operating Expenses$34.76MIncome Tax$2.28MRevenue$20.22M

Latest period ending Dec 31, 2024 · select a line to chart its full history

CERO annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
-15.30M-7.68M-11.97M-11.62M-19.96M
-7.73M-7.29M-11.83M-10.63M-21.65M
-363.00-24,973.00-2,640.00-2,360.00-2.13
CERO annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
3.33M1.60M6.82M19.22M4.14M
6.21M5.13M11.35M24.18M16.64M
8.10M5.08M4.12M5.50M5.51M
1.58M2.94M3.02M3.60M0
-1.89M-42.06M-34.87M-23.43M11.13M
CERO annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2001 Dec 31, 2001
-12.28M-5.79M-11.71M-10.09M-133.00K
13.73M571.68K5.63K60.26K40.00K
1.45M-5.22M-12.40M-10.65M-946.00K